SULPITAC 400MG TABLET is used to manage schizophrenia in affected individuals. It contains Amisulpride which belongs to the group of medicines called Antipsychotics. It works by blocking dopamine D2 receptors (proteins responsible for synthesis and release of dopamine) in brain which results in reduced synthesis of dopamine thus improving thoughts, feelings and behaviour and thereby managing symptoms of schizophrenia in affected individuals.

SULPITAC 400MG TABLET is not recommended for use in patients with breast cancer or prolactin dependent tumor, phaeochromocytoma (type of adrenal gland tumor), and/or pituitary tumor. It is also not recommended for use in patients allergic to Amisulpride or any other ingredients of this medicine. Before taking the medicine, inform your doctor if you have diabetes, Parkinson's disease (type of brain disorder), fits, signs of low potassium levels in blood (such as constipation, fatigue, muscle damage), stroke, kidney problems, and/or liver problems (such as hepatic impairment).

SULPITAC 400MG TABLET is not recommended for use during pregnancy and in women planning for pregnancy. It is also not recommended for use in breast feeding women. It is not recommended for use in children and adolescents (below 18 years of age) which should be used with caution in elderly patients (aged above 65 years). The most common side effects are feeling anxious, drowsy or agitated, constipation, nausea, vomiting, and/or blurred vision. Consult your doctor if any of these symptoms worsens.